Diblock Copolymers of Poly(ethylene oxide)- b -poly(propylene oxide) Stabilize a Blood–Brain Barrier Model under Oxidative Stress
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.4c00608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Pranati P Mondkar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota 55455, United States. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Polyethylene Glycols, Oxidative Stress, Propylene Glycols. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: University of Minnesota.
Abstract (Originalsprache)
The blood-brain barrier (BBB) is a highly restrictive barrier at the interface between the brain and the vascular system. Even under BBB dysfunction, it is extremely difficult to deliver therapies across the barrier, limiting the options for treatment of neurological injuries and disorders. To circumvent these challenges, there is interest in developing therapies that directly engage with the damaged BBB to restore its function. Previous studies revealed that poloxamer 188 (P188), a water-soluble triblock copolymer of poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO), partially mitigated BBB dysfunction in vivo. In the context of stabilization of the damaged BBB, the mechanism of action of PEO-PPO block copolymers is unknown, and there has been minimal exploration of polymers beyond P188. In this study, a human-based in vitro BBB model under oxidative stress was used to investigate polymer-BBB interactions since oxidative stress is closely linked with BBB dysfunction in many neurological injuries and disorders. PEO-PPO block copolymers of varied numbers of chemically distinct blocks, PEO block length, and functionality of the end group of the PPO block were assessed for their efficacy in improving key physiological readouts associated with BBB dysfunction. While treatment with P188 did not mitigate damage in the in vitro BBB model, treatment with three diblock copolymers improved barrier integrity under oxidative stress to a similar extent. Of the considered variations in the block copolymer design, the reduction in the number of chemically distinct blocks had the strongest influence on therapeutic function. The demonstrated efficacy of three alternative PEO-PPO diblock copolymers in this work reveals the potential of these polymers as a class of therapeutics that directly treat the damaged BBB, expanding the options for treatment of neurological injuries and disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota 55455, United States.
- Department of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States.
ORCID-Profile: Pranati P Mondkar, Timothy P Lodge, Samira M Azarin
Förderung
- University of Minnesota
Zitieren
APA
Mondkar, P. P., Seo, H. S., Lodge, T. P., & Azarin, S. M. (2024). Diblock Copolymers of Poly(ethylene oxide)- b -poly(propylene oxide) Stabilize a Blood–Brain Barrier Model under Oxidative Stress. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00608
Vancouver
Mondkar PP, Seo HS, Lodge TP, Azarin SM. Diblock Copolymers of Poly(ethylene oxide)- b -poly(propylene oxide) Stabilize a Blood–Brain Barrier Model under Oxidative Stress. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00608
BibTeX
@article{Mondkar2024,
author = {Mondkar, Pranati P and Seo, Hannah S and Lodge, Timothy P and Azarin, Samira M},
title = {Diblock Copolymers of Poly(ethylene oxide)- b -poly(propylene oxide) Stabilize a Blood–Brain Barrier Model under Oxidative Stress},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.4c00608}
}
EUVIMED